Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (12): 1221-1225.doi: 10.3736/jcim20081203

• Original Clinical Research • Previous Articles     Next Articles

Professor Ling Changquan's experience in treating primary liver cancer: an analysis of herbal medication

Zhen Sun1, Yong-hua Su2, Xiao-qiang Yue2,3()   

  1. 1. Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
    2. School of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China
    3. E-institute of Internal Medicine of Traditional Chinese Medicine, Shanghai Municipal Education Commission, Shanghai 201203, China
  • Received:2008-07-07 Online:2008-12-20 Published:2008-12-15

On the basis of outpatients' medical records concerning primary liver cancer (PLC), data of 552 patients (with 2 020 effective prescriptions) from the Outpatient Department of Changhai Hospital treated by Professor Ling Changquan were collected. The nature, flavor and meridian distribution of the herbs used in the prescriptions were summarized by frequency method, and the features of the herbs used according to syndrome differentiation were analyzed by logistic regression. The couple herbs used were analyzed by cluster analysis. All the data were analyzed in combination with the experience of the specialist. It showed that most of the frequently used herbs were herbs for invigorating the spleen to promote appetite, removing toxic materials to inhibit tumor growth, and activating blood circulation to dissipate blood stasis. These herbs are mostly of plain or cool nature, and mainly of sweet, bitter, or acrid taste. It also showed that the most frequently used herbs for qi deficiency were Astragalus membranaceus, Atractylodes macrocephala, and Pseudostellariae; Caulis Spatholobi and Chinese jujube for blood asthenia; Fructus Corni and Ophiopogon japonicus for yin deficiency; Agastache rugosa, Semen Plantaginis and Poria for water-dampness; cape jasmine fruit and baikal skullcap root for heat excess; peach seed and Radix Paeoniae Rubra for blood stasis; Curcuma wenyujin, Akebia trifoliata and Bupleurum chinense for qi stagnation. A total of 19 pairs of couple herbs were summarized by the cluster analysis.

Key words: Ling Changquan, liver cancer, data analysis, statistical, famous doctors experience

CLC Number: 

  • R249

"

药物 频次 百分率 性味 归经
炒神曲 1 960 97.03 甘、辛、温 脾、胃
炒麦芽 1 960 97.03 甘、平 脾、胃、肝
炒山楂 1 960 97.03 酸、甘、微温 脾、胃、肝
鸡内金 1 960 97.03 甘、平 脾、胃、小肠、膀胱
薏苡仁 1 712 84.75 甘、淡、凉 脾、胃、肺
石见穿 1 620 80.20 苦、辛、凉
猫人参 1 584 78.42 苦、涩、凉
陈皮 1 380 68.32 辛、苦、温 脾、肺
茯苓 1 032 51.09 甘、淡、平 心、脾、肾
山药 988 48.91 甘、平 脾、肺、肾
牡丹皮 944 46.73 甘、苦、微寒 心、肝、肾
赤芍 936 46.34 苦、微寒
鳖甲 760 37.62 甘、咸、寒 肝、肾
太子参 704 34.85 甘、微苦、平 脾、肺
黄芪 564 27.92 甘、微温 脾、肺
白术 556 27.52 甘、苦、温 脾、胃
麦门冬 520 25.74 甘、微苦、微寒 胃、肺、心
当归 496 24.55 甘、辛、温 肝、心、脾
桃仁 480 23.76 苦、甘、平 心、肝、大肠
柴胡 412 20.40 苦、微寒 肝、胆
砂仁 408 20.20 辛、温 脾、胃、肾

"

"

"

类别1 类别2 类别3 类别4
变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数
X5 葫芦壳 0.779 8 X11 灵磁石 0.936 6 X88 石见穿 0.799 0 X32 南北沙参 0.679 9
X51 生大黄 0.778 1 X17 款冬花 0.915 8 X89 猫人参 0.777 6 X71 天门冬 0.625 3
X50 大腹皮 0.685 4 X10 珍珠母 0.904 6 X92 焦三仙 0.734 8 X24 鸡血藤 0.040 1
X63 车前子 0.401 8 X39 朱茯神 0.583 0 X91 鸡内金 0.734 3 X20 侧柏叶 0.396 3
X75 茯苓皮 0.205 9 X46 桑白皮 0.214 1 X90 薏苡仁 0.663 0 X21 仙鹤草 0.337 4
X65 生地黄 0.170 0
X84 泽泻 0.150 3

"

类别5 类别6 类别7 类别8
变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数
X41 蜈蚣 0.916 3 X4 杏仁 0.492 5 X61 佩兰 0.892 5 X14 厚朴 1.000 0
X40 全蝎 0.903 5 X22 栝蒌 0.457 3 X60 藿香 0.875 7 X31 枳实 1.000 0
X12 川芎 0.278 6 X78 砂仁 0.181 2 X57 丹参 0.159 5
X53 桂枝 0.032 6

"

类别9 类别10 类别11 类别12
变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数
X68 白术 0.547 8 X18 旋覆花 0.576 1 X30 火麻仁 0.673 6 X3 茵陈 0.740 7
X76 陈皮 0.310 7 X5 沉香 0.497 5 X631 何首乌 0.669 5 X13 苍术 0.530 1
X83 山药 0.290 8 X18 罂粟壳 0.481 4 X25 威灵仙 0.575 5 X2 金钱草 0.461 0
X67 党参 0.224 7 X64 枳壳 0.109 2 X9 骨碎补 0.131 7 X34 山栀 0.166 7
X45 灵芝 0.171 1 X49 葶苈子 0.080 5 X8 肉苁蓉 0.113 4 X33 连翘 0.077 8
X70 太子参 0.143 9 X47 丝瓜络 0.053 0
X38 合欢皮 0.143 1 X55 川石斛 0.048 6
X23 木香 0.042 8

"

类别9 类别10 类别11
变量 标签 相关系数 变量 标签 相关系数 变量 标签 相关系数
X85 枸杞子 0.481 0 X73 柴胡 0.666 7 X80 赤芍 0.722 6
X28 杜仲 0.426 1 X58 郁金 0.610 9 X81 牡丹皮 0.594 3
X27 牛膝 0.415 8 X59 八月札 0.477 8 X79 桃仁 0.412 6
X42 熟地黄 0.383 7 X74 黄芩 0.321 3 X86 鳖甲 0.167 0
X6 女贞子 0.360 1 X82 当归 0.158 1 X43 北沙参 0.083 1
X7 垂盆草 0.032 4 X77 茯苓 0.097 4 X29 五味子 0.061 4
X66 山茱萸 0.277 2 X36 干蟾皮 0.070 1 X37 蛇莓 0.027 0
X48 大枣 0.243 5 X69 黄芪 0.057 7 X54 天花粉 0.012 4
X72 麦门冬 0.089 0 X35 夏枯草 0.031 8
X26 桑寄生 0.075 7 X56 半夏 0.012 3
X1 炙甘草 0.240 0
[1] 中国抗癌协会肝癌专业委员会. 原发性肝癌的临床诊断与分期标准[J]. 中华肝脏病杂志, 2001,9(6):324
doi: 10.3971/j.issn.1000-8578.912
Committee of Liver Cancer of the Chinese Anti-Cancer Association. Criteria for diagnosis and staging of primary liver cancer[J]. Zhonghua Gan Zang Bing Za Zhi, 2001,9(6):324
[2] Ling CQ, Liu Q, Li DT , et al. Study of a qualitative diagnostic criterion for basic syndromes of traditional Chinese medicine in patients with primary liver cancer[J]. Zhong Xi Yi Jie He Xue Bao, 2005,3(2):95-98
凌昌全, 刘庆, 李东涛 , 等. 原发性肝癌常见中医基本证候定性诊断规范的研究[J]. 中西医结合学报, 2005,3(2):95-98
[3] Huang XB, Li ZX, Chen WQ , et al. Cluster analysis on traditional Chinese medicine syndromes of chronic fatigue syndrome[J]. Zhonghua Zhong Yi Yao Za Zhi, 2006,21(10):592-594
doi: 10.3969/j.issn.1673-1727.2006.10.005
黄小波, 李宗信, 陈文强 , 等. 慢性疲劳综合征的中医证候聚类分析[J]. 中华中医药杂志, 2006,21(10):592-594
doi: 10.3969/j.issn.1673-1727.2006.10.005
[4] Zhang Q, Zhang WT, Wei JJ , et al. Combined use of factor analysis and cluster analysis in classification of traditional Chinese medical syndromes in patients with posthepatitic cirrhosis[J]. Zhong Xi Yi Jie He Xue Bao, 2005,3(1):14-18
张琴, 张文彤, 魏建军 , 等. 公因子和聚类分析联合在肝炎后肝硬化证候分类研究中的应用[J]. 中西医结合学报, 2005,3(1):14-18
[5] Zhang Q, Liu P, Zhang WT , et al. An application of data mining in the research of TCM syndrome theories[J]. Shanghai Zhong Yi Yao Za Zhi, 2006,40(3):3-5
doi: 10.3969/j.issn.1007-1334.2006.03.002
张琴, 刘平, 张文彤 , 等. 数据挖掘技术在中医证候学研究中的应用[J]. 上海中医药杂志, 2006,40(3):3-5
doi: 10.3969/j.issn.1007-1334.2006.03.002
[6] Li DT, Ling CQ, Lang QB , et al. Construction of a therapeutic effect evaluation system for patients with primary liver cancer based on syndrome differentiation in traditional Chinese medicine[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(1):15-22
李东涛, 凌昌全, 郎庆波 , 等. 以证候为内容的原发性肝癌中医疗效评价体系研究[J]. 中西医结合学报, 2007,5(1):15-22
[7] Chen SQ, Zhang JM, Yuan F . Auxiliary analysis with computer on drug administration of Professor Ding Shu-wen in treating tachycardia[J]. Tianjin Zhong Yi Yao, 2006,23(5):423-425
doi: 10.3969/j.issn.1672-1519.2006.05.022
陈守强, 张建民, 袁锋 . 丁书文教授用药规律的计算机辅助分析——治疗心动过速用药分析[J]. 天津中医药, 2006,23(5):423-425
doi: 10.3969/j.issn.1672-1519.2006.05.022
[8] Liu J . Application and significance of cluster analysis in traditional Chinese medical research[J]. Zhong Yi Yao Xue Kan, 2004,22(5):927-928
刘稼 . 聚类分析在中医药研究中的应用及意义[J]. 中医药学刊, 2004,22(5):927-928
[1] Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[2] Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.
[3] Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407.
[4] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[5] Liang-ping Hu, Xiao-lei Bao, Chen-long Lv. Two-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(9): 966-969.
[6] Liang-ping Hu, Xiao-lei Bao, Chen-yi Guo . Two-factor designs unable to examine the interactions (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(8): 853-857.
[7] Liang-ping Hu , Xiao-lei Bao, Chen-long Lü . How to choose an appropriate experimental design type (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(7): 738-742.
[8] Liang-ping Hu, Xiao-lei Bao. How to choose an appropriate experimental design type (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(6): 615-618.
[9] Xiao-lei Bao, Liang-ping Hu. Multifactor designs able to examine the interactions. Journal of Chinese Integrative Medicine, 2012, 10(12): 1371-1374.
[10] Liang-ping Hu, Xiao-lei Bao. Three-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(11): 1229-1232.
[11] Liang-ping Hu, Xiao-lei Bao. Three-factor designs unable to examine the interactions (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(10): 1088-1091.
[12] Qian Zhao, Rui Jin, Bing Zhang, Sen-mao Liu, Min Li, Xin Liu, Lian-zhen Li, Qian Zhang . Ridit analysis of experimental data from animal models of yang deficiency induced by different doses of hydrocortisone. Journal of Chinese Integrative Medicine, 2011, 9(9): 941-947.
[13] Liang-ping Hu, Xiao-lei Bao, Li-xin Tao. Statistical inference and experimental design of univariate qualitative data of paired design. Journal of Chinese Integrative Medicine, 2011, 9(1): 109-112.
[14] LP Hu, XL Bao. Statistical inference and experimental design of univariate quantitative data of single-group design (part one). Journal of Chinese Integrative Medicine, 2010, 8(9): 888-892.
[15] Yi Ge, Liang-ping Hu. Statistical analysis for data of multidimensional contingency table with SAS software package (Part six). Journal of Chinese Integrative Medicine, 2010, 8(4): 385-391.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239